Open Access

Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy

  • Authors:
    • Yanjie You
    • Fangrui Hu
    • Shengjuan Hu
  • View Affiliations

  • Published online on: May 25, 2022     https://doi.org/10.3892/ol.2022.13345
  • Article Number: 224
  • Copyright: © You et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The zinc‑fingers and homeoboxes (ZHX) family members have been characterized as master regulators in cancer initiation and development. The present study performed in silico data‑mining with publicly available datasets and immunohistochemistry to assess the expression status of ZHX factors and the corresponding prognostic implications in liver cancer. Increased ZHX3 mRNA expression was associated with favorable overall survival in patients with liver cancer. Subgroups analyses revealed a significant association between the expression of ZHX factors and outcomes in select patient cohorts. Immunohistochemical analysis supported that ZHX3 expression was an independent prognostic indicator for patient survival. These results suggested that dysregulation of ZHX factors is involved in disease progression and ZHX3 expression may serve as a prognostic biomarker for liver cancer.

Related Articles

Journal Cover

July-2022
Volume 24 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
You Y, Hu F and Hu S: Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy. Oncol Lett 24: 224, 2022
APA
You, Y., Hu, F., & Hu, S. (2022). Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy. Oncology Letters, 24, 224. https://doi.org/10.3892/ol.2022.13345
MLA
You, Y., Hu, F., Hu, S."Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy". Oncology Letters 24.1 (2022): 224.
Chicago
You, Y., Hu, F., Hu, S."Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy". Oncology Letters 24, no. 1 (2022): 224. https://doi.org/10.3892/ol.2022.13345